Alzheimer's drugs & their side effects

Alzheimer's disease is the most common cause of dementia, affecting around 496,000 people in the UK. Dementia is a brain diseases that cause long term loss of the ability to think, mood changes and reason clearly that is severe enough to affect a person's daily functioning. These symptoms occur when the brain is damaged by certain diseases and conditions, including Alzheimer's disease. Alzheimer's disease, first described by the German neurologist Alois Alzheimer, is a physical disease affecting the brain. During the course of the disease, protein 'plaques' and 'tangles' develop in the structure of the brain, leading to the death of brain cells. People with Alzheimer's also have a shortage of some important chemicals in their brain.

LSD(Lysergic acid diethylamide)

LSD(Lysergic acid diethylamide) is the most potent & strongest hallucinogen ever known to man. small Quantity of LSD(25 microgram or 0.000025 g) is enough to cause hallucinations. LSD was first synthesized by Albert Hofmann in 1938 from ergotamine, a chemical derived by Arthur Stoll from ergot, agrain fungus that typically grows on rye. It was synthesized by researchers seeking to create new medicine & first developed in lab of switzerland.

Hofmann discovered the psychedelic properties of LSD in 1943. It was introduced commercially in 1947 for various psychiatric uses, and it quickly became a therapeutic agent that appeared to show great promise. LSD is very potent, with 20–30 µg (micrograms) being the threshold dose.

                                                                                   Albert Hofmann

In the 1950s, officials at the U.S. Central Intelligence Agency (CIA) thought the drug might be applicable to mind control and chemical warfare, the agency's MKULTRA research program propagated the drug among young servicemen and students. The subsequent recreational use of the drug by youth culture in the Western world during the 1960s led to a political firestorm that resulted in its prohibition. Currently, a number of organizations—including the Beckley Foundation, MAPS, Heffter Research Institute and the Albert Hofmann Foundation—exist to fund, encourage and coordinate research into the medicinal and spiritual uses of LSD and related psychedelics.]New clinical LSD experiments in humans started in 2009 for the first time in 35 years.